Univest
Univest
  • Markets

Alembic Gears Up for Q3 Reveal on 12th February; Check Key Expectations Here

  • February 11, 2026
  • Posted by: Ekta Dhawan
  • Category: News
No Comments
Alembic Gears Up for Q3 Results

Click and Sign Up to Get Live Updates on Q3 Results 

Alembic’s Q3 results FY26 are scheduled to be announced on 12th February 2026. Financial analysts anticipate an increase in revenue due to higher sales and a significant rise in PAT.

Table of Contents

Toggle
  • Alembic Q3 Results 2026 Preview
  • Alembic Share Performance 
  • Key Factors to Watch for Alembic Q3 Results FY26
  • Final Thoughts
  • Recent Articles

Alembic Q3 Results 2026 Preview

  • Alembic’s revenue is expected to be in the range of ₹57.92 crore, a 9.47% YoY increase. 
  • Profit After Tax, or PAT, is projected to fall 45.97% YoY. 
  • Net profit is ₹65.39 crore, a fall 45.97% YoY 
  • EBITDA to rise 40.15%

Alembic Share Performance 

  • Over the past six months, Alembic’s share price has fallen by 8.86% to ₹99.25.
  • Moreover, over the past year, the stock has increased by 5.98%.
  • Despite this weak short-term performance, Alembic’s stock has delivered a financially sound 2.02% return over the past 5 years.
  • As of 11th February 2026, the stock traded at ₹99.39 per share.

Key Factors to Watch for Alembic Q3 Results FY26

  • Revenue Growth & Mix: Performance of domestic formulations, US generics, exports, and API business.
  • Profitability & Margins: Trends in EBITDA and net margins amid pricing and cost pressures.
  • US Business Performance: Impact of product launches, approvals, and competition in the US market.
  • R&D Spend & Pipeline: Investment in R&D, ANDA approvals, and future product pipeline progress.
  • Cost Control & Efficiency: Management of operating expenses and input costs.
  • Management Guidance: Outlook on FY26 growth, regulatory environment, and market conditions.

Final Thoughts

Alembic will announce its Q3 FY26 results on 12th February 2026. Analysts expect 9.47% revenue growth, a 45.97% fall in PAT, and a 40.15% rise in EBITDA. Alembic focuses revenue growth, margins, US business performance, R&D pipeline, and management guidance.

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!

Recent Articles

GOCL Corporation Q3 Results FY26 Preview

Godrej Industries Q3 Results FY26 Preview

Godawari Power and Ispat Q3 Results FY26 Preview

Hikal Q3 Results FY26 Preview

Himatsingka Seide Q3 Results FY26 Preview

Igarashi Motors India FY26 Preview

IG Petrochemicals Ltd Q3 Results FY26 Preview

IOL Chemicals & Pharmaceuticals Q3 Results FY26 Preview



Q3 Results Q3 Results 2026
Author: Ekta Dhawan
Ekta Dhawan is a Financial Content Writer at Univest, covering Indian equity markets with a focus on stock analysis, IPOs, and quarterly earnings results. Over 2+ years, she has published 1500+ articles tracking listed companies across sectors, translating complex financial data into clear, actionable insights for retail investors. She holds a Bachelor of Business Administration (BBA) and a Post Graduate Diploma in Management (PGDM), giving her a structured grounding in corporate finance, equity valuation, and capital markets. Her writing moves past surface-level reporting to explain why a stock is moving, what a quarterly result signals, and how investors should interpret it. She also brings expertise in SEO content strategy, keyword research, and on-page optimisation, ensuring articles reach investors actively searching for clarity on market events. All articles are reviewed by Univest's in-house equity research team, led by Ankit Jaiswal, Senior Equity Research Analyst, to meet SEBI editorial standards.

Leave a Reply Cancel reply